Back to Search Start Over

P3.08F.02 MRD Guiding Treatment after Aumolertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model (APPROACH)

Authors :
Zhou, Q.
Pan, Y.
Yang, X.-N.
Yu, Q.-T.
Zhao, W.-H.
Zhang, T.-M.
Liu, A.-W.
Feng, W.-N.
Dong, X.-R.
Yang, Y.
Zhao, M.-F.
Wang, P.-L.
Fan, Y.
Luo, H.
Wang, B.-H.
Shu, Y.-S.
Liu, Y.
Zhao, J.
Bu, Q.
Li, J.
Xu, F.
Sun, L.-H.
Liu, S.-Y.M.
Wu, Y.-L.
Source :
Journal of Thoracic Oncology; October 2024, Vol. 19 Issue: 10, Number 10 Supplement 1 pS338-S338, 1p
Publication Year :
2024

Details

Language :
English
ISSN :
15560864 and 15561380
Volume :
19
Issue :
10, Number 10 Supplement 1
Database :
Supplemental Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Periodical
Accession number :
ejs67694723
Full Text :
https://doi.org/10.1016/j.jtho.2024.09.608